WORLD
British Drugmaker GSK Said Its Antibody-based COVID-19 Therapy Developed with U.S. Partner ... - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'British drugmaker GSK said its antibody-based COVID-19 therapy developed with U.S. partner Vir Biotechnology is effective against all mutations of the new Omicron coronavirus variant, citing new data from early-stage studies ...'
British drugmaker GSK said its antibody-based COVID-19 therapy developed with U.S. partner Vir Biotechnology is effective against all mutations of the new Omicron coronavirus variant, citing new data from early-stage studies https://t.co/XnveVD8Hiz pic.twitter.com/KOHqdqmU32— Reuters (@Reuters) December 7, 2021
(The above story first appeared on LatestLY on Dec 07, 2021 05:36 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
